ANDA 88415, held by Pharmafair. Prednisolone Sodium Phosphate.
As of Nov 16, 2026, ANDA 88415 (Predair), held by Pharmafair, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| PredairEQ 0.11% PHOSPHATE ยท solution/drops;ophthalmic | Prednisolone Sodium Phosphate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters